Bio-Rad Laboratories (BIO) Other Non-Current Assets (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Other Non-Current Assets of $102.8 million for Q1 2026, down 0.87% year-over-year from $103.7 million in Q1 2025, and little changed quarter-over-quarter from $102.7 million in Q4 2025.
Bio-Rad Laboratories (BIO) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Other Non-Current Assets for 18 consecutive years, with $102.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 0.87% year-over-year to $102.8 million; the TTM figure through Mar 2026 stood at $102.8 million (down 0.87% YoY), while the FY2025 annual figure was $102.7 million, up 0.79% from the prior year.
- Other Non-Current Assets was little changed at $102.8 million in Q1 2026 per BIO's latest filing, from $102.7 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $109.0 million in Q3 2025 and bottomed at $92.9 million in Q1 2024.
- Historically, Other Non-Current Assets has averaged $100.8 million across 5 years, with a median of $101.8 million in 2022.
- On a YoY basis, Other Non-Current Assets climbed as much as 12.73% in 2022 and fell as far as 9.21% in 2022.
- Bio-Rad Laboratories' Other Non-Current Assets stood at $94.6 million in 2022, then rose by 0.32% to $94.9 million in 2023, then gained by 7.38% to $101.9 million in 2024, then grew by 0.79% to $102.7 million in 2025, then grew by 0.1% to $102.8 million in 2026.
- Business Quant data shows BIO's Other Non-Current Assets at $102.8 million in Q1 2026, $102.7 million in Q4 2025, and $109.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Bio-Rad Laboratories | 10.10 Bn | 8.48 Bn | 345.80 Mn | 101.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 101.70 Mn |
| Mar 31, 2026 | 102.80 Mn |
| Dec 31, 2025 | 102.70 Mn |
| Sep 30, 2025 | 109.00 Mn |
| Jun 30, 2025 | 107.90 Mn |
| Mar 31, 2025 | 103.70 Mn |
| Dec 31, 2024 | 101.90 Mn |
| Sep 30, 2024 | 103.62 Mn |
| Jun 30, 2024 | 98.19 Mn |
| Mar 31, 2024 | 92.87 Mn |
| Dec 31, 2023 | 94.90 Mn |
| Sep 30, 2023 | 98.47 Mn |
| Jun 30, 2023 | 100.06 Mn |
| Mar 31, 2023 | 95.51 Mn |
| Dec 31, 2022 | 94.60 Mn |
| Sep 30, 2022 | 101.77 Mn |
| Jun 30, 2022 | 100.89 Mn |
| Mar 31, 2022 | 103.93 Mn |
| Dec 31, 2021 | 104.20 Mn |
| Sep 30, 2021 | 106.63 Mn |